| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3974361 | Seminars in Fetal and Neonatal Medicine | 2008 | 7 Pages |
Abstract
SummaryPrenatal fetal sex determination is undertaken in women at high risk of serious genetic disorders affecting a specific sex. Traditionally, this is undertaken by invasive testing, usually chorionic villus sampling, which carries a risk of miscarriage of around 1%. The identification of cell-free fetal DNA in the maternal circulation has allowed the development of ‘non-invasive prenatal diagnostic tests’, which permit fetal sex determination without risk to the pregnancy.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Kirstin M. Finning, Lyn S. Chitty,